chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FEELING ACHY; EYES SWELLED SHUT; LIPS SWELLED; FACE HAD TURNED BRIGHT RED; FACE SWELLED TWICE ITS NORMAL SIZE; CHILLS; FEVER; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212A21A expiry: UNKNOWN) dose was not reported, administered on 24-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 25-SEP-2021, the patient experienced feeling achy. On 25-SEP-2021, the patient experienced eyes swelled shut. On 25-SEP-2021, the patient experienced lips swelled. On 25-SEP-2021, the patient experienced face had turned bright red. On 25-SEP-2021, the patient experienced face swelled twice its normal size. On 25-SEP-2021, the patient experienced chills. On 25-SEP-2021, the patient experienced fever. Treatment medications included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feeling achy, chills, fever, eyes swelled shut, lips swelled, face had turned bright red and face swelled twice its normal size was not reported. This report was non-serious.
Very severe headache 3-1/2 days after shot that lasted over 4 hours, unlike any headache I've ever had. I am not prone to headaches; This is a spontaneous report received from a contactable consumer. A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not reported), via an unspecified route of administration at the right arm on 09Feb2021 10:45 at single dose for COVID-19 immunization. The patient's medical history included asthma and had allergies to contrast dye and shellfish. Concomitant medications included serrapeptase. On 12Feb2021 8:30 pm, the patient had very severe headache and lasted over 4 hours. It was reported that unlike any headache patient had ever had and she was not prone to headaches. Outcome of event was reported as recovered on unspecified date on Feb2021.  Information about batch/lot number has been requested.
About 11 days post Moderna booster,  extreme itchiness started on scalp and migrated towards back of neck and eventually throughout entire body. The areas that were scratched became red and welts. Took a benadryl which improved itchines but once that wore off the hives and itchiness returned. Went to urgent care which prescribed at 5 day course of prednisone as well as hydroxozine which helped with hives and itchiness but i then developed dermatographia. Visited dermatologist who affirmed that he as seen other patients have this delayed reaction post  Moderna booster. Have been on 180 mg of allegra once a day as well as hydroxozine at night. If i do not take antihistamines the hives and extreme itchiness return. Dermatographia is still present - develop red marks with flushing feel when too  much pressure is applied to skin - usuallly resolves in 5-10 min.
AT SITE OF VARIVAX ADMINISTRATION, CHILD DEVELOPED VESICULAR-LIKE LESIONS ON LEFT THIGH WITH PRURITIS AT SITE.
lump in left breast under the arm pit.  It was tender to the touch; It is tender to the touch and about the size of a small pea; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 12May2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis (Non-Surgically Diagnosed Endometriosis). The patient was allergic to penicillin. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021, the patient experienced a lump in the left breast under the armpit. It was tender to the touch and about the size of a small pea. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events lump in the left breast under the armpit and it was tender to the touch and about the size of a small pea were unknown at the time of the report.  No follow-up attempts are possible. No further information is expected.
About 10-15 minutes following vaccination, patient turned very pale, was sweating, and feeling lightheaded and dizzy. (Patient mentioned he had a great fear of needles prior to vaccine administration) A nearby ARNP took his blood pressure and he read very low..he was advised to lay down and elevate his feet to improve his blood pressure. He felt better. 911 was called and fire department was dispatched just in case. Fire department came and assessed his vitals. Patient started feeling better and was eventually able to sit up. He sat for a few more minutes before he left the store.
rash at injection site by next morning (much like mosquito bites appear).  complaint of itching. resolved with treatment with 1? triamcinolone cream.
Chills, Night Sweats, Hives. Fever, Cough, Dizziness, Itching, Liver Problems.
Polyarthralgias and headache which lasted 4-5 days. Symptoms have resolved without treatment.
Narrative:  Pt received J&J COVID vaccine on 9/7/21 and within approx 42 days (on 10/21/21) presented to local ER with SOB and swelling of leg, dx with right leg DVT and PE. This was first incidence of PE or DVT. Past h/o iliac artery stent in 2016.
There were no adverse events.  I felt absolutely amazing, younger, and as if my cells were rejuvenated.  I had more energy, there was a feeling of happiness, and odd relaxation.
HEADACHE; FEVER; BODY ACHE; CHILLS; This spontaneous report received from a patient concerned a 61 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, Expiry) dose was not reported, administered on 25-MAR-2021 at 18:30 to the left arm for prophylactic vaccination. No concomitant medications were reported.  On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced fever. On 25-MAR-2021, the subject experienced body ache. On 25-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient was recovering from headache, fever, body ache, and chills. This report was non-serious.  Additional information received from patient on 31-Mar-2021. The following information was updated and incorporated into the case narrative: Due diligence was scheduled. Upon review, the following information was amended: Vaccination site was updated in therapy details and narrative.
Within 30 minutes of shot, pain in arm near shoulder when lifting arm outward from body.  Conditioned worsened as days passed, unable to raise arm away from body without severe pain near shoulder.  Company nurse recommended ice and pain reliever.  After 4 weeks without improvement, saw physician, who prescribed Naproxin and referred me to Orthopedic.  Naproxin offers some relief.  6 wks: Ortho X-rayed, and prescribed physical therapy (Began this morning).
After 2nd vax felt like they had flu and no fever. with major pain  in spine , now it is a burning/hurting pain.Stomach problems, called Dr and they gave her muscle relaxers and medicine for itching
Starting the end of February 2022, I thought I had a bug bite. I realized it wasn't a bug bite and called my doctor. They told me I had shingles. I had a pretty bad episode of nerve pain and put on gabapentin. It lasted about 6 weeks and then it resolved for the most part. I still have episodes of nerve pain but I no longer take the gabapentin anymore.
I was vaccinated on 01/20/2021, and on 01/28/2021 in the morning, my left arm developed a burning, itching, red circle at the injection site.
Headache night before (11/5/07), felt fainty.  The next A.M. headache was severe, neck hurting, nausea, dizzy.  All symptoms were still present at 11:30 A.M.  11/6/07 when she came in to be seen by doctor.
Patient received first vaccine 5/9/2021  Reported unscheduled vaginal bleeding and severe cramping 5/10/2021  Lost to follow-up after second dose
Vaccine failure. 1st 1/2 dose on 10-27-05. 2nd 1/2 dose on 11-29-05.  Flu A positive and symptomatic on 1-23-06.
DIZZINESS, DISORIENTED THREE TIMES DURING THE DAY, AND TWICE AGAIN ON 10/11/2011
The patient was under 18 yrs  old that was overlooked by the vaccinator. The patient is fine and no treatment has been needed. The error  was only noticed as the consent form was being filed.
Horrible diarrhea a few days after vaccine. Diagnosed with Ulcerative Colitis weeks later.
Swelling and hardness at injection site; Redness at injection site; itchiness at injection site; Swelling and hardness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swelling and hardness at injection site), INJECTION SITE ERYTHEMA (Redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site) and INJECTION SITE INDURATION (Swelling and hardness at injection site) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE SWELLING (Swelling and hardness at injection site), INJECTION SITE ERYTHEMA (Redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site) and INJECTION SITE INDURATION (Swelling and hardness at injection site). At the time of the report, INJECTION SITE SWELLING (Swelling and hardness at injection site), INJECTION SITE ERYTHEMA (Redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site) and INJECTION SITE INDURATION (Swelling and hardness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
I received the shot on the morning of September 29.  By the evening, I had fever and chills.  I took 400 mg of ibuprofen at 7 pm , 500 mg of acetaminophen at 10 pm and then went to bed.  My fever broke at 1 am the next day.  I began vomiting at 10 am on Saturday, September 30.  I vomited again around 2 pm that day.  I did not eat or drink anything that day.  Sunday, October 1, I was able to eat and drink, but noticed in the evening tingling sensations in my feet and legs.  On Monday, October 2, the tingling sensation was more intense and travelled to my hips.  By the end of the work day, my legs were numb and weak.  October 3 and 4th, the numbness and weakness worsened and it was difficult for me to walk.  I made an appointment with my PCP.  I saw him on October 5th and he had strong clinical suspicion that I had Guillen-Barre.  He drew labs which all came back normal.  He made an appointment for a neurologist for Monday, October 9.  Each day between October 5th and 9th, I saw improvement in my weakness and numbness.  I saw the neurologist on Monday, October 9 and he also has strong suspicion that I had Guillen-Barre, but a mild case that was healing on its own and required no treatment or hospitalization.
She states, "left arm and both hands left arm hurts, and feels sharp stabbing pain both hands go numb cramping in both legs knees to ankle wakes up from sleep ."
Onset 12/28/2021 - Extreme fatigue, depression/anxiety, hopelessness, muscle pain, headaches, night sweats, cold extremeties, skin texture change (dry, flaky, itchy), post nasal drip, hairloss, eye redness. Self Treatment: OTC Claritin, Ibuprofen & prenatal vitamins daily. Outcomes: pain relief & post nasal drip relief. Diagnosis: Low WBC, BURR CELLS +1 and OVALCYTES +1 Referral to Cancer Institute 3/28/2022 @ 11:30 am.
headache, disorientation, nausea all from 4/3/2021 continuing to this date. Yesterday the headache was so bad I did vomit.
The brother-in-law of a 47 year old female reported that his sister-in-law received a dose of flu shield on 12/12/2001 and developed an injection site reaction characterized by redness and swelling 3-4 days post-vaccination. She also experienced dizziness, "fluctuating" blood pressure, and facial numbness. The reporter indicated that the redness and swelling at the injection site resolved; however, as of 01/22/2002, the dizziness, fluctuating blood pressure, and facial numbness persisted. NO further info was available at the date of this report.
JOHNSON & JOHNSON COVID-19 VACCINE KILLS WOMAN; This spontaneous report received from a consumer via a company representative via social media concerned a 52 year adult female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, therapy start date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died from unknown cause of death. As per reporter "Johnson and Johnson COVID-19 (coronavirus disease) vaccine kills woman, 52, two weeks after jab". It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).  Version created to amend previously reported information on 03-MAR-2022. Upon review the following information was amended: Amendment Adverse Event (The case validity assessment was updated to valid from the previously incorrect assessment of non-valid).; Sender's Comments: V1: Version created to amend previously reported information on 03-MAR-2022. Upon review the following information was amended: Amendment Adverse Event (The case validity assessment was updated to valid from the previously incorrect assessment of non-valid). This updated information does not alter the causality of previously reported events. 20220323554-COVID-19 VACCINE AD26.COV2.S -Johnson and Johnson COVID-19 vaccine kills woman. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
throat pain; a runny nose; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (throat pain) and RHINORRHOEA (a runny nose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Aug-2021, the patient experienced OROPHARYNGEAL PAIN (throat pain) and RHINORRHOEA (a runny nose). At the time of the report, OROPHARYNGEAL PAIN (throat pain) and RHINORRHOEA (a runny nose) outcome was unknown.            Concomitant medications included psychiatric medications (unspecified). No treatment medications were provided.
It was a mild pain in his chest and when he was breathing; Fever; Had inflammation from the vaccine; His D-dimer was elevated; This is a spontaneous report from a contactable consumer. A 12-year-old male (same age at vaccination) patient (reporters son) received second dose of bnt162b2 (BNT162B2, Solution for injection, lot: EW0177) via unspecified route of administration on 08Jun2021 around 1 pm as single dose in upper arm for COVID-19 immunization. Medical history was not reported. concomitant medications reported was Children's Multivitamins. As per reporter, Well, it's a multivitamin, so it has a bunch in it. It's a Children's Multivitamins. The patient previously took first dose of bnt162b2 (Lot: EW0183) on 18May2021 at the age of year old in upper arm around 11:30. No prior Vaccinations (within 4 weeks) was reported. As per reported, reporter stated, I was calling I have the, I guess my son received the COVID Vaccination (captured as suspect) and I have the care sheet and it said to call if you had experienced a reaction, so I was calling to report the reaction that he had. Reporter stated, He has it wasn't (incomplete sentence) I guess it was a mild pain in his chest and when he was breathing. Reporter also stated, "You know what, he had a fever also I don't know if you wanted to add that. No, I guess I don't know if you want, the doctor at the ER said that he had inflammation from the vaccine that it was believe me I guess that was his conclusion. Reporter took him after the vaccine because the next day he was having problems we took him to the emergency room, and they did an ECG they did chest X-rays they did a CT scan and he had blood work. Result of Test included everything was normal except for his blood work, his D-dimer was elevated. Regarding weight reporter stated maybe 80 pounds. He got lab test after the vaccine. Before the vaccine he didn't get anything. Outcome of events was reported as recovering.   No follow-up attempts possible. No further information expected. Information on Lot/Batch number was available. Additional information has been requested.
A consumer report has been received. The report concerns a patient. Female consumer, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that while administering FLUMIST QUADRIVALENT, it went into first nostril causing patient to swallow the FLULMIST QUADRIVALENT. The outcome of the event of FLUMIST QUADRIVALENT went into first nostril causing patient to swallow the FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Patient called, return call to her at 1:30pm.  No fever.  c/o bright red streak from injection site & near armpit.  Advice-take temp, 2 Tylenol & cool compress.  I returned phone call at 3:45pm, no change.  Patient did talk to her MD office, same advice given.  She was told to call me if no improvement.
LYMPH NODE SWELLED UNDERNEATH ARM; ACHES ALL OVER; NOT FEEL GREAT; SPLITTING HEADACHE; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, Laboratory data included: COVID-19 virus test negative (NR: not provided) NEGATIVE, and Influenza antibody test negative (NR: not provided) Negative. On an unspecified date, the subject experienced lymph node swelled underneath arm, aches all over, not feel great, splitting headache, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and the outcome of lymph node swelled underneath arm, not feel great, splitting headache and aches all over was not reported. This report was non-serious.; Sender's Comments: V0  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
ELEVATED D-DIMER; SHORTNESS OF BREATH; COLD; GOT SICK; This spontaneous report received from a parent concerned a 22 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced shortness of breath. On 07-APR-2021, the subject experienced cold. On 07-APR-2021, the subject experienced got sick. On 09-APR-2021, the subject experienced elevated d-dimer. Laboratory data included: Fibrin D dimer (NR: not provided) elevated levels of 0.6. On 09-APR-2021 15:30, Laboratory data included: CT scan (NR: not provided) negative for blood clots. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cold, got sick, shortness of breath and elevated d-dimer was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Patient arrived at observation parking lot at approximately 10:55 after receiving COVID-19 Vaccine to left upper arm. Patient was stopped by observation staff and asked about any previous history of anaphylaxis. Patient denied. Patient was instructed to remain in line for 15 observation period and was instructed to set timer to phone and honk if she experienced any adverse reactions. Patient got in line.  At approximately 11:00, patient honked horn. This nurse and one other nurse ran to vehicle. Patient was waving arm out of the window. Other nurse instructed to call for help and this nurse assessed patient. Patient stated ?I don?t feel good. My throat feels weird. I think it?s closing.? Initial vital sign were HR-85 and Pulse ox 98%.  1103-This nurse gave initial dose of epi to R Outer Thigh. 911 called by other staff.  1105-20G IV started to LAC.  1107-O2 given at 3L via nasal cannula. 50 mg Benadryl given via IV. Lost IV access after medication administration due to rain and being unable to secure line.  1108-2nd IV attempt was unsuccessful to LUA. 1111-O2 90%. Non rebreather applied and O2 bumped to 50L. Surgical mask applied over non rebreather. 1111-2nd dose of Epi given to R outer thigh. 1112-BP-160/70. Fire arrived on scene. 1113- 3rd IV attempt to RIJ was unsuccessful.  1116- 20G IV to R hand successful with flush.  1120- NS initiated.  1121-BP- 160/84. 1122-EMS arrived. 1126-Patient loaded into ambulance. 1131- Patient left via ambulance.  Patient was alert and responsive through the entire ordeal. Patient was able to answer questions. Patient expressed relief from throat swelling after initial Epi. Pupils equal and reactive. Patient stated, ?I feel better. My throat is dry, and I feel sleepy.? Patient vocalized pain from IV attempts. After 2nd dose of Epi, patient?s hands were cold to touch and VS were not able to be read from pulse ox. Pulse obtained via palpation. Pulse was 52 after all medication administration by staff. Patient reported taking Zyrtec and duloxetine prior to coming for vaccine today. Denies any history of anaphylaxis. Patient requested this nurse call her husband. Husband notified of event per patient request.
-I got the booster on 9/11 - Started having symptoms overnight on 9/23. I was woken up by intensely itchy feet and hands -On 9/26 I started getting hives as well -Every evening around 8 or 9 pm I get hives and get super itchy, my feet start to itch too -The symptoms are worse at night and are still waking me up in the night if I don't take antihistamines -Dr. diagnosed this as chronic spontaneous urticaria